A diagnostic dilemma following risk-reducing surgery for <it>BRCA1 </it>mutation – a case report of primary papillary serous carcinoma presenting as sigmoid cancer

<p>Abstract</p> <p>Background</p> <p>Women that carry germ-line mutations for <it>BRCA1 </it>or <it>BRCA2 </it>genes are at an increased risk of developing breast, ovarian and peritoneal cancer. Primary peritoneal carcinoma is a rare tumour histologically identical to papillary serous ovarian carcinoma. Risk-reducing surgery in the form of mastectomy and oophorectomy in premenopausal women has been recommended to prevent breast and ovarian cancer occurrence and decrease the risk of developing primary peritoneal cancer.</p> <p>Case presentation</p> <p>We present a case report of a woman with a strong family history of breast cancer who underwent risk-reducing surgery in the form of bilateral salpingo-oophorectomy following a mastectomy for a right-sided breast tumour. Following the finding of a <it>BRCA1 </it>mutation, a prophylactic left-sided mastectomy was performed. After remaining well for twenty-seven years, she presented with rectal bleeding and altered bowel habit, and was found to have a secondary cancer of the sigmoid colon. She was finally diagnosed with primary papillary serous carcinoma of the peritoneum (PSCP).</p> <p>Conclusion</p> <p>PSCP can present many years after risk-reducing surgery and be difficult to detect. Surveillance remains the best course of management for patients with known <it>BRCA </it>mutations.</p